Becton, Dickinson and Co. | BDX - Loan Capital


Becton, Dickinson and Co. reported $13.51B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Agilent USD 3.64B 594M Jun/2026
Align Technology USD 0 0 Dec/2024
AngioDynamics USD 5.6M 100K Sep/2025
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Bio-Rad Laboratories USD 803M 100K Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
Cooper Companies USD 1.92B 54.8M Jun/2026
Danaher USD 25.15B 7.59B Jun/2026
Dentsply International USD 2B 10M Jun/2026
Dexcom USD 1.3B 200K Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Globus Medical USD 398K 38K Mar/2026
Insulet USD 929.5M 0 Jun/2026
Integra LifeSciences USD 1.83B 2.05M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.34B 183M Jun/2026
Medtronic USD 25.62B 502M Jun/2026
Solventum Corp USD 4.57B 2M Jun/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 809K Jun/2026
Teleflex USD 2.72B 206.24M Jun/2026
Terumo JPY 209.52B 109.61B Jun/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
Zimmer Biomet Holdings USD 6.28B 17.6M Jun/2026